Richard Oakley of the Alzheimer's Society spoke to Newsweek about why now is an "exciting time" in the battle against the ...

In recognition of Alzheimer’s Awareness Month, the Centers for Medicare and Medicaid Services should review and revise policies for Alzheimer’s disease therapies to clear the path for early ...

A new drug to treat Alzheimer’s Disease has been approved by Health Canada and it is the first drug that targets an ...

New results on the oral Alzheimer's pill, valiltramiprosate, claims it can slow down the brain atrophy that causes ...

The new treatment approach targets restoring normal blood vessel function instead of focusing on neurons or other brain cells, which has been the common strategy until now. A team of scientists co-led ...

The experimental pill ALZ-801 slowed memory decline by 50% and reduced brain shrinkage in early Alzheimer's patients with ...

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Canada Inc. announced today that Health Canada ...

Early detection of Alzheimer's disease has come a step closer thanks to a new measurement method developed by chemists at ...

Researchers used supramolecular nanoparticles to repair the brain’s vascular system and reverse Alzheimer’s in mice. Instead ...

On Real Possibilities with AARP Michigan, associate professor of translational neuroscience Dr. Scott Counts from Michigan ...

The University of California, San Francisco, has received a gift of $100 million for its Memory and Aging Center, dedicated ...